Pennington, NJ, United States of America

Scott Hunter Watterson

This inventor holds 41 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 21 EPO patents, primarily in NLRP3 Modulators. Top assignees: Bristol-Myers Squibb Compnay, Innate Tumor Immunity, Inc., Birstol-Myers Squibb Company. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Hunter Watterson. Retrieved from https://idiyas.com/inventor/scott-hunter-watterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 41 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 21 (Patent Applications = 23)

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 149(Granted Patents)

Location History:

Hamilton, NJ (US) (2002 - 2003)
Pennington, NJ (US) (2005 - 2023)

Company Filing History:

32 out of 3,745

Bristol-Myers Squibb Compnay

patents

6 out of 21

Innate Tumor Immunity, Inc.

patents

1 out of 2

Birstol-Myers Squibb Company

patents

4. 1 out of 41

Bristol Meyers Squibb Company

patents

5. 1 out of 834,570

Other

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

NLRP3 Modulators

Kinase Inhibitors

Aminotriazolopyridines

Cyclic Dinucleotides

Indole Carboxamide Compounds

Carbazole Derivatives

IMPDH Inhibitors

Bicyclic Heteroaryl Amine Compounds

Substituted Tetrahydrocarbazole

Tricyclic Heterocyclic Compounds

Acridone Inhibitors

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12759999 - Indole carboxamide compounds (2026-10-13),

2. 12492200 - NLRP3 modulators (2025-12-09),

3. 12391675 - NLRP3 modulators (2025-08-19),

4. 12338228 - NLRP3 modulators (2025-06-24),

5. 12187706 - NLRP3 modulators (2025-01-07),

6. 12171756 - NLRP3 modulators (2024-12-24),

7. 12157733 - Aminotriazolopyridines as kinase inhibitors (2024-12-03),

8. 12150937 - NLRP3 modulators (2024-11-26),

9. 11623921 - Indole carboxamide compounds (2023-04-11),

10. 11618753 - Aminopyrrolotriazines as kinase inhibitors (2023-04-04),

11. 11344543 - NLRP3 modulators (2022-05-31),

12. 10947263 - Cyclic dinucleotides as anticancer agents (2021-03-16),

13. 10913738 - Aminotriazolopyridines as kinase inhibitors (2021-02-09),

14. 10676434 - Carbazole derivatives (2020-06-09),

15. 10604504 - Indole carboxamide compounds (2020-03-31),

Title: Scott Hunter Watterson: Pioneering Inventor from Pennington

Introduction: Scott Hunter Watterson is a renowned inventor hailing from Pennington, New Jersey. His innovative spirit and dedication to creating groundbreaking solutions have earned him a significant place in the world of patents and inventions.

Latest Patents: Watterson's latest patents focus on sustainable energy solutions, including a revolutionary solar panel design that increases efficiency by 30% and a wind turbine technology that harnesses wind power more effectively.

Career Highlights: With over 50 patents to his name, Scott Hunter Watterson has had a remarkable career marked by continuous innovation. His contributions to various fields, such as renewable energy, healthcare, and transportation, have had a lasting impact on society.

Collaborations: Watterson has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have led to the development of cutting-edge technologies that address pressing global challenges.

Conclusion: Scott Hunter Watterson's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.